News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Actuate Therapeutics receives FDA IND clearance for oral elraglusib programme
Tuesday, May 12, 2026Actuate Therapeutics Inc has received Investigational New Drug IND clearance from the US Food and Drug Administration FDA for a Phase study of the oral formulation of elraglusib
Sironax receives FDA Fast Track status for SIR2501 in chemotherapy-induced peripheral neuropathy
Tuesday, May 12, 2026Sironax has received Fast Track designation from the US Food and Drug Administration FDA for its SARM inhibitor SIR for the treatment of chemotherapyinduced peripheral neuropathy CIPN
Delos Capital and AP Biosciences partner to launch biotech companies for next-generation antibody development
Tuesday, May 12, 2026Delos Capital and AP Biosciences Inc have announced a strategic collaboration to establish and incubate new biotechnology companies focused on developing nextgeneration antibody therapies
Nuclera Introduces Antibody Screening Service for AI-Based Drug Discovery
Monday, May 11, 2026Nuclera has launched a new antibody screening service aimed at supporting AIdriven antibody discovery and helping researchers move more quickly from hit generation to lead selection
Rznomics Secures FDA RMAT Designation for Liver Cancer Candidate RZ-001
Monday, May 11, 2026Rznomics has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration for RZ its investigational therapy for hepatocellular carcinoma HCC
Merck Completes Acquisition of Terns Pharmaceuticals
Wednesday, May 06, 2026Merck known as MSD outside the United States and Canada has completed the acquisition of Terns Pharmaceuticals Inc
CS Analytical Announces Major Laboratory Expansion
Tuesday, May 05, 2026CS Analytical Laboratory a cGMP FDAregistered and inspected contract laboratory focused on package and container testing for the pharmaceutical biotechnology and medical device sectors
